Cite
HARVARD Citation
Harter, P. et al. (2020). Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). International journal of gynecological cancer. 30 (12), pp. 1997-2001. [Online].